Peritoneal mesothelioma malignant+1
Not recruitingStudy on Talazoparib for Maintenance Treatment in Patients with Advanced Malignant Pleural or Peritoneal Mesothelioma After Initial Chemotherapy
Study on Talazoparib for Maintenance Treatment in Patients with Advanced Malignant Pleural or Peritoneal Mesothelioma After Initial Chemotherapy
- Disease:Peritoneal mesothelioma malignantPleural mesothelioma malignant
- Substances:Talazoparib
France- Participants:18–64 years · 65+ years
- Substances:Talazoparib
- Sponsor:Hospices Civils De Lyon











